Tetra Bio-Pharma Overview
- Founded
-
2007
- Status
-
Public
- Employees
-
33
- Stock Symbol
-
TBP
- Investments
-
8
- Share Price
-
$0.05
- (As of Wednesday Closing)
Tetra Bio-Pharma General Information
Description
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
Contact Information
Website
www.tetrabiopharma.com
Formerly Known As
GrowPros Cannabis Ventures
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
TSE
Primary Office
- 2316 Saint Joseph Boulevard
- Orleans, Ontario K1C 1E8
- Canada
+1 (343) 000-0000
Tetra Bio-Pharma Timeline
Tetra Bio-Pharma Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $0.05 | $0.04 - $0.26 | $19.7M | 423M | 279K | -$0.07 |
Tetra Bio-Pharma Financials Summary
|
In Thousands, USD |
TTM 28-Feb-2022 | FY 2021 30-Nov-2021 | FY 2020 30-Nov-2020 | FY 2019 30-Nov-2019 |
|---|---|---|---|---|
| EV | 24,616 | 64,932 | 31,703 | 55,124 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (34,627) | (40,078) | (15,775) | (9,885) |
| Net Income | (36,259) | (41,594) | (19,686) | (11,494) |
| Total Assets | 6,895 | 5,926 | 22,595 | 21,497 |
| Total Debt | 2,076 | 2,442 | 1,540 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tetra Bio-Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tetra Bio-Pharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical program
Drug Discovery
Orleans, Canada
33
As of 2021
000.00
000000000
000.00
000000
s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
London, United Kingdom
0
As of 0000
0000
00.00
0000-00-00
00000000
0000
00000
labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
00000 000000000000000 000 0000000000000
Vancouver, Canada
00.000
000000000
00.000
Add Comparison
Tetra Bio-Pharma Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Cannabinoid Technologies | Formerly VC-backed | London, United Kingdom | 0 | 0000 | 00000000 | 0000 |
| 00000 00000000 00. | Corporation | Vancouver, Canada | 00.000 | 000000000 | 00.000 | |
| 000-000000 | Corporation | Toronto, Canada | 00 | 000.00 | 000000000 | 000.00 |
Tetra Bio-Pharma Patents
Tetra Bio-Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3115179-A1 | Cannabis compositions and methods | Pending | 18-Dec-2018 | 000000000 | |
| CA-3027876-A1 | Cannabis compositions and methods | Pending | 18-Dec-2018 | 000000000 | |
| EP-3897615-A1 | Cannabis compositions and methods | Pending | 18-Dec-2018 | 000000000 | |
| AU-2019409889-A1 | Cannabis compositions and methods | Pending | 18-Dec-2018 | A61K9/007 |
Tetra Bio-Pharma Executive Team (24)
Tetra Bio-Pharma Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000 00 | Self | Chairman & Board Member | 000 0000 |
| 0000 000000 | Self | Board Member | 000 0000 |
| 000000000 0000 | Tetra Bio-Pharma | Board Member | 000 0000 |
| 000 00000000000 00.0 | Tetra Bio-Pharma | Chief Executive Officer & Board Member | 000 0000 |
| 0000 000 | Self | Board Member | 000 0000 |
Tetra Bio-Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Tetra Bio-Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tetra Bio-Pharma Investments & Acquisitions (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 (0000 0 | 03-Jun-2020 | 000000000 | Drug Discovery | 000000 0é | |
| 000 000000000 | 21-Aug-2019 | 00000 0000 | Pharmaceuticals | 000 00000 | |
| 00000 000000 | 01-May-2019 | 0000000000 | 000.00 | Drug Discovery | 000 00000 |
| 00000 0000000 | 29-Apr-2019 | 00000 0000 | Drug Delivery | 000 00000 | |
| Phytopain Pharma | 19-Mar-2018 | Secondary Transaction - Private | 000.00 | Pharmaceuticals | 0000000 0 |
Tetra Bio-Pharma Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Panag Pharma | Drug Discovery | Halifax, Canada | 2014 |
| 0000000 000000000 | Gold Mining | Ottawa, Canada | 0000 |
Tetra Bio-Pharma Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 22-Jun-2016 | 000000000000000000 | 00000 | Completed |
|
| Export Hydro | 06-Nov-2015 | Merger/Acquisition | 000 | Completed |